Epigenetic and Drug Response Modulation of Epigalocaten-In-3-Gallate in <i>Staphylococcus aureus</i> with Divergent Resistance Phenotypes
Healthcare-associated methicillin-resistant <i>Staphylococcus aureus</i> infections represent extremely high morbidity and mortality rates worldwide. We aimed to assess the antimicrobial potential and synergistic effect between Epigalocatenin-3-gallate (EGCG) and different antibiotics in...
Main Authors: | Ana Rita Mira, Ana Sofia Zeferino, Raquel Inácio, Mariana Delgadinho, Miguel Brito, Cecília R. C. Calado, Edna Ribeiro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/3/519 |
Similar Items
-
Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases—Focus on Epigenetic Mechanisms
by: Marta Włodarczyk, et al.
Published: (2024-02-01) -
Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity
by: Adriana Elena Bulboacă, et al.
Published: (2022-02-01) -
Development and Optimization of Epigallocatechin-3-Gallate (EGCG) Nano Phytosome Using Design of Experiment (DoE) and Their In Vivo Anti-Inflammatory Studies
by: Mohammad H. Shariare, et al.
Published: (2020-11-01) -
The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
by: Víctor Marín, et al.
Published: (2023-06-01) -
Epigallocatechin-3-Gallate Alleviates Liver Oxidative Damage Caused by Iron Overload in Mice through Inhibiting Ferroptosis
by: Chunjing Yang, et al.
Published: (2023-04-01)